[{"OperatingLeaseWeightedAverageDiscountRatePercent_0_FY_pure":0.081,"AdvertisingExpense_4_FY_USD":3200000.0,"PropertyPlantAndEquipmentGross_0_FY_USD":10476000.0,"PropertyPlantAndEquipmentNet_0_FY_USD":3864000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":13458000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4_FY_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4_FY_pure":0.0226,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_4_FY_pure":0.58,"SellingGeneralAndAdministrativeExpense_4_FY_USD":129736000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_4_FY_shares":1709498.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":54847060.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":53137562.0,"StockholdersEquity_0_FY_USD":410945000.0,"GrossProfit_1_FY_USD":54335000.0,"FiniteLivedIntangibleAssetsNet_0_FY_USD":23037000.0,"AmortizationOfIntangibleAssets_4_FY_USD":1505000.0,"PurchaseObligationDueInThirdYear_0_FY_USD":500000.0,"PurchaseObligationDueInSecondYear_0_FY_USD":1000000.0,"PurchaseObligationDueInNextTwelveMonths_0_FY_USD":9200000.0,"ProceedsFromStockOptionsExercised_4_FY_USD":6264000.0,"UnrecognizedTaxBenefits_0_FY_USD":9741000.0,"UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_4_FY_USD":1518000.0,"UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_4_FY_USD":8223000.0,"AdditionalPaidInCapitalCommonStock_0_FY_USD":631307000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_4_FY_USD":394517000.0,"PaymentsToAcquireIntangibleAssets_4_FY_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_FY_USD":267057000.0,"NumberOfOperatingSegments_4_FY_Segment":1.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_4_FY_USD":327227000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":45072000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_FY_USD":45650000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4_FY_USD":-16099000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":13458000.0,"Liabilities_0_FY_USD":72803000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":483748000.0,"LiabilitiesCurrent_0_FY_USD":59505000.0,"PaymentsToAcquirePropertyPlantAndEquipment_4_FY_USD":1019000.0,"NumberOfReportableSegments_4_FY_Segment":1.0,"EarningsPerShareBasic_4_FY_USD":2.17,"EarningsPerShareBasic_1_FY_USD":0.08,"OperatingIncomeLoss_1_FY_USD":4243000.0,"OperatingLeaseCost_4_FY_USD":2300000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_FY_USD":9700000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_4_FY_USD":6264000.0,"CurrentForeignTaxExpenseBenefit_4_FY_USD":81000.0,"OperatingLeaseLiability_0_FY_USD":14602000.0,"OperatingLeaseLiabilityCurrent_0_FY_USD":2147000.0,"OperatingIncomeLoss_4_FY_USD":22810000.0,"OperatingLeaseLiabilityNoncurrent_0_FY_USD":12455000.0,"OperatingLeaseRightOfUseAsset_0_FY_USD":11180000.0,"CurrentStateAndLocalTaxExpenseBenefit_4_FY_USD":1161000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4_FY_USD":10.19,"ResearchAndDevelopmentExpense_4_FY_USD":48649000.0,"ShortTermLeaseCost_4_FY_USD":400000.0,"ShareBasedCompensation_4_FY_USD":13458000.0,"OtherIncome_4_FY_USD":6218000.0,"OperatingLeasePayments_4_FY_USD":2500000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_FY_USD":5501000.0,"CurrentFederalTaxExpenseBenefit_4_FY_USD":0.0,"Revenues_4_FY_USD":227188000.0,"EarningsPerShareDiluted_4_FY_USD":2.11,"EarningsPerShareDiluted_1_FY_USD":0.08,"CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization_4_FY_USD":24488000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":227188000.0,"EffectiveIncomeTaxRateContinuingOperations_4_FY_pure":-2.981,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4_FY_pure":0.21,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_pure":-3.576,"Revenues_1_FY_USD":60930000.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_4_FY_pure":-0.005,"EffectiveIncomeTaxRateReconciliationOtherAdjustments_4_FY_pure":0.027,"EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_4_FY_pure":-0.01,"EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_4_FY_pure":0.018,"EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_4_FY_pure":0.109,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-220665000.0,"CostsAndExpenses_4_FY_USD":204378000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4_FY_USD":-1000.0,"EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_4_FY_pure":0.03,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_FY_USD":2332000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_FY_USD":2355000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_FY_USD":2420000.0,"DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_0_FY_USD":1994000.0,"DeferredTaxLiabilitiesOther_0_FY_USD":414000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":1932024.0,"OtherComprehensiveIncomeLossTax_4_FY_USD":71000.0,"InventoryFinishedGoodsNetOfReserves_0_FY_USD":1140000.0,"DefinedContributionPlanCostRecognized_4_FY_USD":800000.0,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_4_FY_pure":0.5,"DeferredTaxAssetsValuationAllowance_0_FY_USD":8155000.0,"DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_4_FY_pure":0.06,"InventoryNoncurrent_0_FY_USD":2824000.0,"EmployeeRelatedLiabilitiesCurrent_0_FY_USD":6597000.0,"InventoryWorkInProcessNetOfReserves_0_FY_USD":0.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_FY_USD":27590000.0,"IncreaseDecreaseInInventories_4_FY_USD":722000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_4_FY_USD":3099000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":2764000.0,"InventoryNet_0_FY_USD":1140000.0,"AccountsReceivableNetCurrent_0_FY_USD":26367000.0,"DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_0_FY_USD":1468000.0,"DeferredTaxAssetsTaxDeferredExpenseOther_0_FY_USD":1301000.0,"OtherAccruedLiabilitiesCurrent_0_FY_USD":1673000.0,"DeferredFederalIncomeTaxExpenseBenefit_4_FY_USD":-85624000.0,"DeferredForeignIncomeTaxExpenseBenefit_4_FY_USD":-16000.0,"DeferredIncomeTaxAssetsNet_0_FY_USD":87680000.0,"DeferredIncomeTaxExpenseBenefit_4_FY_USD":-87767000.0,"DeferredIncomeTaxLiabilities_0_FY_USD":2408000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_4_FY_USD":313000.0,"DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0_FY_USD":2101000.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_4_FY_USD":-2127000.0,"DeferredTaxAssetsNet_0_FY_USD":87680000.0,"DeferredTaxAssetsOperatingLossCarryforwardsDomestic_0_FY_USD":52034000.0,"DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_0_FY_USD":8700000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_4_FY_USD":6000.0,"OtherComprehensiveIncomeLossNetOfTax_4_FY_USD":248000.0,"DeferredTaxAssetsTaxCreditCarryforwardsResearch_0_FY_USD":12000000.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_0_FY_USD":5298000.0,"DeferredTaxAssetsGross_0_FY_USD":98243000.0,"OtherLiabilitiesNoncurrent_0_FY_USD":843000.0,"Depreciation_4_FY_USD":1387000.0,"AssetsCurrent_0_FY_USD":354136000.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":6264000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-68309000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":45947000.0,"AccruedProfessionalFeesCurrent_0_FY_USD":5376000.0,"AccruedRoyaltiesCurrent_0_FY_USD":5904000.0,"NetIncomeLoss_4_FY_USD":115553000.0,"NetIncomeLoss_1_FY_USD":4216000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":115801000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_FY_USD":6612000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_FY_USD":13000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":249000.0,"ProceedsFromIssuanceOfCommonStock_4_FY_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_FY_USD":20103000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_FY_USD":8182000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":2326000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_FY_USD":2488000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_FY_USD":236000.0,"Assets_0_FY_USD":483748000.0,"IncreaseDecreaseInAccountsReceivable_4_FY_USD":-2342000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":14500000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4_FY_USD":28794000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4_FY_USD":234000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4_FY_USD":29028000.0,"IncomeTaxExpenseBenefit_4_FY_USD":-86525000.0,"CommitmentsAndContingencies_0_FY_USD":null,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.001,"PreferredStockSharesAuthorized_0_FY_shares":20000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4_FY_USD":3508000.0,"PreferredStockSharesIssued_0_FY_shares":0.0,"PreferredStockValue_0_FY_USD":0.0,"AssetsFairValueDisclosure_0_FY_USD":274027000.0,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.001,"CommonStockSharesAuthorized_0_FY_shares":150000000.0,"CommonStockSharesIssued_0_FY_shares":53549612.0,"CommonStockSharesOutstanding_0_FY_shares":53549612.0,"CommonStockValue_0_FY_USD":54000.0,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"OtherNoncashIncomeExpense_4_FY_USD":-1785000.0,"Ticker":"VNDA","CIK":"1347178","name":"VANDA PHARMACEUTICALS INC.","OfficialName":"Vanda Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"pure","footnote":"nan","Market Cap":"633424667.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200226"}]